AAVantgarde announces completion of recruitment in STELLA natural history study
Summary
MILAN, April 21, 2026 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company pioneering next-generation gene therapies for in...
Description
MILAN, April 21, 2026 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company pioneering next-generation gene therapies for in...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source